News

Booming sales of Wegovy powered the company to become Europe's most valuable, but it has lost over $400 billion in market ...
Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...
Eli Lilly (LLY) reports Q2 earnings on Aug 7, with booming diabetes and weight-loss drug sales driving strong growth.
Eli Lilly offers an annual dividend yield of 0.78%. So, how can investors exploit its dividend yield to pocket a regular $500 ...
Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second quarter ...
You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...
The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications.
Experts have long-debated whether dogs can tell if a human companion is pregnant. Dr. Rachel Barrack, DVM, owner of Animal ...
Lilly Erickson’s journey in skateboarding started in Hawaii with a Target board covered in hearts—now she’s riding for ...
Eli Lilly and Company, a pharmaceutical manufacturing facility, will be receiving up to $100 million in performance-based ...
After beating AstraZeneca’s Calquence in quarterly revenue for the first time at the end of 2024, BeOne Medicines’ Brukinsa ...
Eli Lilly is investing up to $4 billion in the Bristol project and Wisconsin plans to provide up to $100 million in ...